PHARMAZEUTISCHE FORMULIERUNG

European patent · EP3793517 · Deleted

Register entry

Publication number
EP3793517
Application number
EP19728321
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 15, 2019
Published
Mar 24, 2021
Granted
Apr 19, 2023
Deleted
Dec 23, 2023
Reason
Annual fee unpaid
IPC classes
A61K 9/00 (2006.01)
A61K 9/70 (2006.01)
A61K 47/36 (2006.01)
A61K 31/352 (2006.01)
Priority
GB 201807942 16.05.2018
PCT application
PCT/EP2019/062534 15.05.2019
PCT publication
WO2019/219773 21.11.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 28, 2024

    Change

    Published in Swissreg on 28.02.2024

  2. Dec 23, 2023

    Deleted, fee unpaid

    Published in Swissreg on 23.12.2023

  3. Apr 19, 2023

    Granted

    Published in Swissreg on 19.04.2023

Parties

Holder

Klaria Pharma Holding AB

Virdings Allé 2, 754 50 Uppsala, SE

Inventor

BOYER, Scott

754 50 Uppsala, SE

HÜBINETTE, Fredrik

754 50 Uppsala, SE

SINGH, Shalini

754 50 Uppsala, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.